130 related articles for article (PubMed ID: 6511143)
1. Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities.
Piccoli M; Saito T; Chirigos MA
Int J Immunopharmacol; 1984; 6(6):569-76. PubMed ID: 6511143
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
[TBL] [Abstract][Full Text] [Related]
3. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
[TBL] [Abstract][Full Text] [Related]
4. Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes.
Saito T; Welker RD; Fukui H; Herberman RB; Chirigos MA
Cell Immunol; 1985 Feb; 90(2):577-89. PubMed ID: 3871375
[TBL] [Abstract][Full Text] [Related]
5. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2.
Budzynski W; Chirigos M; Gruys E
Cancer Immunol Immunother; 1987; 24(3):253-8. PubMed ID: 3594488
[TBL] [Abstract][Full Text] [Related]
7. Enhanced macrophage and natural killer cell antitumor activity by various molecular weight maleic anhydride divinyl ethers.
Bartocci A; Papademetriou V; Chirigos MA
J Immunopharmacol; 1980; 2(1):149-58. PubMed ID: 6256453
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation and antitumor effects of MVE-2 in mice.
Talmadge JE; Maluish AE; Collins M; Schneider M; Herberman RB; Oldham RK; Wiltrout RH
J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720
[TBL] [Abstract][Full Text] [Related]
9. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.
Zhang SR; Salup RR; Urias PE; Twilley TA; Talmadge JE; Herberman RB; Wiltrout RH
Cancer Immunol Immunother; 1986; 21(1):19-25. PubMed ID: 3484675
[TBL] [Abstract][Full Text] [Related]
11. Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers.
Saito T; Ruffman R; Welker RD; Herberman RB; Chirigos MA
Cancer Immunol Immunother; 1985; 19(2):130-5. PubMed ID: 3845849
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
[TBL] [Abstract][Full Text] [Related]
13. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.
Talmadge JE; Herberman RB; Chirigos MA; Maluish AE; Schneider MA; Adams JS; Philips H; Thurman GB; Varesio L; Long C
J Immunol; 1985 Oct; 135(4):2483-91. PubMed ID: 2411797
[TBL] [Abstract][Full Text] [Related]
14. Biological response modifiers: regulators of the cellular immune system and adjuvants in antitumor therapy.
Chirigos MA; Schlick E; Saito T; Gruys E
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):27-33. PubMed ID: 3486334
[TBL] [Abstract][Full Text] [Related]
15. Modulation of myelopoiesis by CSF or CSF-inducing biological response modifiers.
Schlick E; Ruffmann R; Hartung K; Chirigos MA
J Immunopharmacol; 1985; 7(1):141-66. PubMed ID: 3874241
[TBL] [Abstract][Full Text] [Related]
16. Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity.
Puccetti P; Santoni A; Riccardi C; Holden HT; Herberman RB
Int J Cancer; 1979 Dec; 24(6):819-25. PubMed ID: 232496
[TBL] [Abstract][Full Text] [Related]
17. Relationship of molecular weight to antiviral and antitumor activities and toxic effects of maleic anhydride-divinyl ether (MVE) polyanions.
Morahan PS; Barnes DW; Munson AE
Cancer Treat Rep; 1978 Nov; 62(11):1797-803. PubMed ID: 103618
[TBL] [Abstract][Full Text] [Related]
18. Biological characterization of MVE-2 and poly ICLC.
Schlick E; Welker R; Piccoli M; Ruffmann R; Chirigos M
Prog Clin Biol Res; 1984; 161():511-24. PubMed ID: 6483902
[No Abstract] [Full Text] [Related]
19. In vivo induction of terminal differentiation of malignant myelopoietic progenitor cells by CSF-inducing biological response modifiers.
Schlick E; Ruscetti FW
Blood; 1986 Apr; 67(4):980-7. PubMed ID: 3485461
[TBL] [Abstract][Full Text] [Related]
20. Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors.
Loveless SE; Munson AE
Cancer Res; 1981 Oct; 41(10):3901-6. PubMed ID: 7285000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
